Vertex Pharmaceuticals Inc. buy Citigroup Inc.
Start price
14.11.24
/
50%
€470.80
Target price
14.11.25
€545.96
Performance (%)
-19.47%
End price
15.11.25
€379.15
Summary
This prediction ended on 15.11.25 with a price of €379.15. The price of Vertex Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -19.47%. Citigroup_Inc_ has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Vertex Pharmaceuticals Inc. | 1.794% | 1.794% | 30.360% |
| iShares Core DAX® | 0.437% | 5.640% | 7.806% |
| iShares Nasdaq 100 | 1.057% | 0.282% | 27.239% |
| iShares Nikkei 225® | 1.769% | 0.406% | 49.266% |
| iShares S&P 500 | 0.368% | 1.920% | 22.336% |
Comments by Citigroup_Inc_ for this prediction
In the thread Trading Vertex Pharmaceuticals Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $575.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat
Current prediction by Citigroup_Inc_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€346.50
02.10.25
02.10.25
€489.84
02.10.26
02.10.26
26.09%
14.08.26
14.08.26
Stopped prediction by Citigroup_Inc_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€435.00
10.03.26
10.03.26
€503.22
10.03.27
10.03.27
0.44%
14.08.26
14.08.26